Drug Profile
DBX 31
Alternative Names: DBX-31Latest Information Update: 18 Oct 2021
Price :
$50
*
At a glance
- Originator DeoBioSciences
- Class Antineoplastics; Immunotherapies; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer